We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,567

New case highlights the dangers of failing to write comprehensive patent specifications
  • Fisher Adams Kelly Callinans
  • Australia
  • October 20 2016

The success or failure of a patent in court can depend entirely on the Court's definition of a single word in the specification. Some words of course

RNAi - patentable subject matter after all
  • Davies Collison Cave
  • Australia
  • October 19 2016

In a decision handed down on 13 October 2016 involving an application in the name of Arrowhead Research Corporation (Arrowhead) the Australian Patent

Interfering RNA (iRNA) is no interference to manner of manufacture in Australia
  • FB Rice
  • Australia
  • October 18 2016

Following the Australian High Court decision in Myriad, isolated nucleic acid was found not to constitute patent eligible subject matter. The High

Australian Patent Office defies expectations by saying yes to gene patents
  • Shelston IP Pty Ltd
  • Australia
  • October 17 2016

The Australian Patent Office has reversed its current examination practice in Arrowhead Research Corporation 2016 APO 70 by confirming that

Contributing to a patent claim might not make you a co-inventor
  • FPA Patent Attorneys
  • Australia
  • October 14 2016

A decision by the Full Federal Court of Australia has found that even if you have contributed to an invention and your contribution has led to a

IPR Evidence and Trial Impact for Practitioners
  • Baker Botts LLP
  • Australia, Global, USA
  • October 4 2016

Although initially pegged as sounding the death knell for the majority of challenged patent claims, over the past couple of years, the Patent Trial

Patent extension of term available for second indications for pharmaceutical substances produced with recombinant DNA
  • Phillips Ormonde Fitzpatrick
  • Australia
  • September 27 2016

The Administrative Appeals Tribunal (AAT) has overturned a decision of the Commissioner of Patents and found that Swiss-style claims can form the

Australian Patent Office overruled - Swiss-style claims can confer eligibility for patent term extensions
  • Shelston IP Pty Ltd
  • Australia
  • September 22 2016

As previously reported, the Australian Patent Office issued two decisions in August 2015 in which it found that Swiss-style claims (which are of the

3 Rounds to Lucas Mill in Chinese Patent Case
  • FPA Patent Attorneys
  • Australia, China
  • September 21 2016

In 2014 Lucas Mill discovered a knockoff of its Patented portable sawmill being sold online and took immediate action for infringement of its Chinese

Unfulfilled promises - potentially fatal to patent validity
  • Davies Collison Cave
  • Australia
  • September 16 2016

While some politicians seem to get away with making sometimes promises during an election campaign, with little prospect of fulfilling them all